Literature DB >> 14670997

Folliculostellate cells determine the susceptibility of lactotropes to estradiol's mitogenic action.

Souichi Oomizu1, Kirti Chaturvedi, Dipak K Sarkar.   

Abstract

Estradiol is known to increase lactotropic cell proliferation, but estradiol susceptibility varies among human populations and among various strains of rats. We had reported that folliculostellate (FS) cells regulate estradiol's mitogenic action on lactotropes; therefore, we studied their role in determining the susceptibility to estradiol in a high estradiol-responsive rat strain, Fischer 344 (F344), and in a low-responsive strain, Sprague Dawley (SD). Determination of total S-100-positive FS cells in the pituitary revealed that F344 rats have significantly more FS cells than do SD rats. Estradiol treatment did not change the number of FS cells in both F344 and SD rats. When cotransplanted with F344 pituitaries under the kidney capsule or cocultured with F344-derived lactotropes in vitro, FS cells derived from F344 rats increased estradiol's mitogenic action. They also increased estradiol's mitogenic action on SD-derived lactotropes in primary cultures. However, SD-derived FS cells failed to increase estrogen's action on F344- or SD-derived lactotropes. The levels of basic fibroblast growth factor production and secretion by TGF-beta 3 and estradiol were much higher in F344-derived FS cells than in SD-derived FS cells. However, the lactotropes' growth response to basic fibroblast growth factor was similar in both strains. These data suggest that cell-cell interaction between FS cells and lactotropes regulates estradiol's mitogenic action on lactotropes and also determines lactotrope susceptibility to the steroid.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14670997      PMCID: PMC2869487          DOI: 10.1210/en.2003-0965

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  38 in total

1.  Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma.

Authors:  J D Shull; T J Spady; M C Snyder; S L Johansson; K L Pennington
Journal:  Carcinogenesis       Date:  1997-08       Impact factor: 4.944

2.  Truncated estrogen receptor product-1 suppresses estrogen receptor transactivation by dimerization with estrogen receptors alpha and beta.

Authors:  E M Resnick; D A Schreihofer; A Periasamy; M A Shupnik
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

3.  Analysis of homogeneous populations of anterior pituitary folliculostellate cells by laser capture microdissection and reverse transcription-polymerase chain reaction.

Authors:  L Jin; I Tsumanuma; K H Ruebel; J M Bayliss; R V Lloyd
Journal:  Endocrinology       Date:  2001-05       Impact factor: 4.736

4.  Opposing actions of two transforming growth factor-beta isoforms on pituitary lactotropic cell proliferation.

Authors:  S Hentges; M Pastorcic; A De; N Boyadjieva; D K Sarkar
Journal:  Endocrinology       Date:  2000-04       Impact factor: 4.736

5.  Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3.

Authors:  T Matsuda; T Yamamoto; A Muraguchi; F Saatcioglu
Journal:  J Biol Chem       Date:  2001-09-12       Impact factor: 5.157

6.  Genetic bases of estrogen-induced pituitary growth in an intercross between the ACI and Copenhagen rat strains: dominant mendelian inheritance of the ACI phenotype.

Authors:  T J Spady; K L Pennington; R D McComb; J D Shull
Journal:  Endocrinology       Date:  1999-06       Impact factor: 4.736

7.  Different functions of QTL for estrogen-dependent tumor growth of the rat pituitary.

Authors:  D L Wendell; S B Daun; M B Stratton; J Gorski
Journal:  Mamm Genome       Date:  2000-10       Impact factor: 2.957

8.  Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells.

Authors:  J Gloddek; U Pagotto; M Paez Pereda; E Arzt; G K Stalla; U Renner
Journal:  J Endocrinol       Date:  1999-03       Impact factor: 4.286

9.  Transforming growth factor-beta3 stimulates lactotrope cell growth by increasing basic fibroblast growth factor from folliculo-stellate cells.

Authors:  S Hentges; N Boyadjieva; D K Sarkar
Journal:  Endocrinology       Date:  2000-03       Impact factor: 4.736

10.  Cellular distribution and gene regulation of estrogen receptors alpha and beta in the rat pituitary gland.

Authors:  N A Mitchner; C Garlick; N Ben-Jonathan
Journal:  Endocrinology       Date:  1998-09       Impact factor: 4.736

View more
  15 in total

1.  Persistent ERK/MAPK activation promotes lactotrope differentiation and diminishes tumorigenic phenotype.

Authors:  Allyson Booth; Tammy Trudeau; Crystal Gomez; M Scott Lucia; Arthur Gutierrez-Hartmann
Journal:  Mol Endocrinol       Date:  2014-12

2.  Global analysis of gene expression in the estrogen induced pituitary tumor of the F344 rat.

Authors:  Douglas L Wendell; Adrian Platts; Susan Land
Journal:  J Steroid Biochem Mol Biol       Date:  2006-09-26       Impact factor: 4.292

3.  Isolation and characterization of rat pituitary endothelial cells.

Authors:  Kirti Chaturvedi; Dipak K Sarkar
Journal:  Neuroendocrinology       Date:  2006-10-04       Impact factor: 4.914

Review 4.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

Review 5.  Genesis of prolactinomas: studies using estrogen-treated animals.

Authors:  Dipak K Sarkar
Journal:  Front Horm Res       Date:  2006       Impact factor: 2.606

6.  Mediation of basic fibroblast growth factor-induced lactotropic cell proliferation by Src-Ras-mitogen-activated protein kinase p44/42 signaling.

Authors:  Kirti Chaturvedi; Dipak K Sarkar
Journal:  Endocrinology       Date:  2005-01-06       Impact factor: 4.736

7.  The Balance of PI3K and ERK Signaling Is Dysregulated in Prolactinoma and Modulated by Dopamine.

Authors:  Allyson K Roof; Siwanon Jirawatnotai; Tammy Trudeau; Crystal Kuzyk; Margaret E Wierman; Hiroaki Kiyokawa; Arthur Gutierrez-Hartmann
Journal:  Endocrinology       Date:  2018-06-01       Impact factor: 4.736

8.  Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas.

Authors:  Hande Mefkure Ozkaya; Nil Comunoglu; Fatma Ela Keskin; Buge Oz; Ozlem Asmaz Haliloglu; Necmettin Tanriover; Nurperi Gazioglu; Pinar Kadioglu
Journal:  Endocrine       Date:  2015-11-17       Impact factor: 3.633

9.  Fibroblast growth factor-2 autofeedback regulation in pituitary folliculostellate TtT/GF cells.

Authors:  George Vlotides; Yen-Hao Chen; Tamar Eigler; Song-Guang Ren; Shlomo Melmed
Journal:  Endocrinology       Date:  2009-04-09       Impact factor: 4.736

10.  The characteristic change in the distribution of S-100 immunoreactive folliculostellate cells in rat anterior pituitary upon long-term estrogen treatment is prevented by concomitant progesterone treatment.

Authors:  Andrea Heinzlmann; Katalin Köves
Journal:  Endocrine       Date:  2008-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.